Phase II Clinical Trial of Dasatinib First Line Therapy for Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms D-FIRST
- 06 Dec 2016 Final results of the D-First study, presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
- 01 Apr 2015 Results published in the American Journal of Hematology.
- 07 Nov 2011 New trial record